Hepatitis Management Programme
In 2023, it is estimated that approximately 410,000 individuals were living with chronic hepatitis B in Hong Kong, which might increase their risk of progressing to liver diseases such as cirrhosis and liver cancer if left unmanaged1. The ‘Hepatitis Management Programme’ (Programme) at CUHK Medical Clinic, which includes the Hepatitis Screening Programme and the Hepatitis B Management Programme, is designed to offer patients the early detection, monitoring, and personalised care for hepatitis infections, particularly, chronic hepatitis B.
Potential threats of Hepatitis A, B, and C
Hepatitis A virus (HAV) is primarily spread through the “faecal-oral” route, where individuals having contact with contaminated objects (for example, shellfish or water tainted by the virus). Most people fully recover with lifelong immunity, but a small fraction of the infected people may face fatal complications, such as fulminant hepatitis (acute liver failure).
Hepatitis B virus (HBV) is spread through contact with blood or body fluids of an infected person (such as blood contact via contaminated items or needles), mother-to-infant transmission during delivery, and sexual contact.
- According to the Population Health Survey 2020–22 conducted by the Department of Health, about 40% of those tested positive for hepatitis B surface antigen are unaware of their condition, and about 70% of them lack medical follow-up1.
Chronic Hepatitis B (CHB) is a lifelong infection. Without treatment, CHB may lead to severe liver issues such as cirrhosis and liver cancer.
Hepatitis C virus (HCV) is mostly spread through infected blood or body fluids and can cause both acute and chronic hepatitis. In 2023, it is estimated that around 17,000 individuals had hepatitis C in Hong Kong1. Around 70% of those infected with HCV will develop chronic HCV infection which may lead to cirrhosis and liver cancer.
Hepatitis A, B, and C have similar symptoms yet varying incubation periods, and they require blood tests for accurate diagnosis. Early diagnosis, treatment, and adequate management are crucial to prevent severe complications.
1Viral Hepatitis Control Office, Department of Health, The Government of the Hong Kong Special Administrative Region. Thematic Report on Viral Hepatitis (Population Health Survey 2020-22). Retrieved 6 March 2025.https://www.hepatitis.gov.hk/english/health_professionals/thematic_report_on_viral_hepatitis.html
Symptoms of Hepatitis B
Programme Features
Screening
Get tested for hepatitis to check whether you have been infected.
Awareness and Action
Individuals who are identified as uninfected and lacking hepatitis antibodies through screening can choose to receive vaccinations* to prevent hepatitis.
*Vaccination is an optional item that will be charged separately.
Hepatitis B Management
Provide doctor consultation and further screening to individuals who are tested positive for hepatitis B to enable early detection and monitoring of complications from chronic hepatitis B, such as cirrhosis and liver cancer.
Programme Details and Fee
Hepatitis Screening Programme
Testing for Hepatitis A, B, and liver function to detect infections early, assess liver health, and guide preventive care are critical for avoiding serious complications like cirrhosis or liver cancer.
| |||||||||||||||||||||||||||||
| Investigation Items | Objectives | Have you had a Liver Function Test in the last 6 months? | |||||||||||||||||||||||||||
| NO | YES | ||||||||||||||||||||||||||||
|
| ✔ | ✔ | ||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
|
| ✔ | ✔ | ||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
|
| ✔ | ✔ | ||||||||||||||||||||||||||
|
| ✔ | ✔ | ||||||||||||||||||||||||||
|
| ✔ | ✔ | ||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
|
| ✔ | |||||||||||||||||||||||||||
| Discounted Fee (HKD) | $ 2,100 | $ 1,800 | |||||||||||||||||||||||||||
| Original Fee (HKD) | $ 4,070 | $ 3,440 | |||||||||||||||||||||||||||
|
Hepatitis B Management Programme
Chronic Hepatitis B patient should receive regular medical assessment. This Hepatitis B Management Programme provides essential follow-up doctor consultation and screening to monitor disease progression and complications.
This programme is designed for:
- Individuals who tested positive for Hepatitis B during screening
- People diagnosed with Chronic Hepatitis B (CHB)
- Patients at risk of liver complications due to Hepatitis B
| |||||||||||||||||||||||
| Investigation Items | Objectives | Have you had a Liver Function Test | |||||||||||||||||||||
| NO | YES | ||||||||||||||||||||||
|
| ✔ | ✔ | ||||||||||||||||||||
| |||||||||||||||||||||||
|
| ✔ | ✔ | ||||||||||||||||||||
|
| ✔ | ✔ | ||||||||||||||||||||
| |||||||||||||||||||||||
|
| ✔ | |||||||||||||||||||||
| Discounted Fee (HKD) | $ 2,680 | $ 2,380 | |||||||||||||||||||||
| Original Fee (HKD) | $ 3,540 | $ 2,910 | |||||||||||||||||||||
Note: Certain investigation items, such as imaging and tests, in the health check programmes and the Health Plus Check-up Scheme will be conducted at third-party service venue(s). Please contact us for further details.
‘Health Plus’ Check-up Scheme
Investigation Items
FibroScan
Measures liver stiffness (for fibrosis) and Controlled Attenuation Parameter (CAP) for liver fat
Antibody against Hepatitis C Virus (Anti-HCV)
To determine whether a person has past exposure to HCV
HBeAg
Monitoring phases of chronic Hepatitis B virus infection
Anti-HBe
Monitoring phases of chronic Hepatitis B virus infection
Service Hours
- MON - FRI:
9:30AM - 6:30PM
SAT:
9:30AM - 1:30PM
SUN AND PUBLIC HOLIDAYS:
CLOSED
Booking and enquiry
(852) 3468 7141
CUHK Medical Clinic (Tsim Sha Tsui)
5/F, Podium Plaza, 5 Hanoi Road,
Tsim Sha Tsui, Kowloon, Hong Kong
Important Notes
- The Programme aims to provide health monitoring and guidance for individuals at risk of or being affected by hepatitis.
- Advance booking is required for the Programme.
- Avoid staying up late, drinking, or strenuous exercising the day before your check-up.
- Please notify the doctor of any medication that you are currently using, especially medication used on long-term basis for diseases such as hypertension, diabetes, and/or cardiovascular diseases, before performing any test.
- Please notify the medical team prior to any blood draw if you have blood or needle phobia or have any bleeding disorders or are taking anticoagulants (Such as Warfarin, NOACs, etc.).
- Please follow instructions from the medical team during your check-up. If you experience any discomfort, notify the team immediately.
- Participants are responsible for any costs associated with additional tests, vaccinations, and/or medical consultation beyond the service scope of the relevant programme.
- If the doctor determines that a participant is not suitable to receive the services under the relevant programme, or the relevant programme is not applicable to the participant, CUHK Medical Clinic will only charge doctor consultation fee and (if applicable) any related diagnostic and/or medication fees/charges according to its/their prevailing prices.
- All items in the Programme are fixed. If, for whatever reason, a participant is unable to complete all the items under the relevant programme, there will be no refund or exchange for items not completed.
- Unless otherwise specified by CUHK Medical Clinic, any offer (such as the Discounted Fee) under the Programme cannot be used in conjunction with other offers or discounts.
- Any offer under the Programme is not transferable and cannot be exchanged for cash or other products or services, and any fees paid for the services under the Programme are not refundable and cannot be exchanged for other products or services.
- In case of any dispute, the decision of CUHK Medical Clinic Limited shall be final and conclusive.